Efficacy and safety of intradetrusor onabotulinumtoxinA injection for managing paediatric non-neurogenic overactive bladder: A prospective case-series study

Objectives: To evaluate the outcome of intradetrusor onabotulinumtoxinA (Botox®; Allergan Inc., Dublin, Ireland) (IDB) injection in children and adolescents with non-neurogenic overactive bladder (OAB) refractory or resistant to treatment. Patients and Methods: In all, 91 patients underwent evaluati...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Dakhakhny, Amr S., El-Karamany, Tarek M., El-Atrebi, Mohamed, Gharib, Tarek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Paediatric Urology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6600069/
https://www.ncbi.nlm.nih.gov/pubmed/31285927
http://dx.doi.org/10.1080/2090598X.2019.1600993

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6600069/
https://www.ncbi.nlm.nih.gov/pubmed/31285927
http://dx.doi.org/10.1080/2090598X.2019.1600993

Ejemplares similares